816 related articles for article (PubMed ID: 35002503)
1. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
[TBL] [Abstract][Full Text] [Related]
2. An enlightening role for cytokine storm in coronavirus infection.
Zhao Z; Wei Y; Tao C
Clin Immunol; 2021 Jan; 222():108615. PubMed ID: 33203513
[TBL] [Abstract][Full Text] [Related]
3. The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm.
Zimecki M; Actor JK; Kruzel ML
Int Immunopharmacol; 2021 Jun; 95():107571. PubMed ID: 33765614
[TBL] [Abstract][Full Text] [Related]
4. Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID-19 Cytokine Storm.
Meng QF; Tian R; Long H; Wu X; Lai J; Zharkova O; Wang JW; Chen X; Rao L
Adv Mater; 2021 May; 33(20):e2100012. PubMed ID: 33837596
[TBL] [Abstract][Full Text] [Related]
5. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
Ramasamy S; Subbian S
Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
[TBL] [Abstract][Full Text] [Related]
6. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
Cabler SS; French AR; Orvedahl A
Trends Mol Med; 2020 Dec; 26(12):1078-1085. PubMed ID: 33051104
[TBL] [Abstract][Full Text] [Related]
7. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
Front Immunol; 2021; 12():589095. PubMed ID: 33995341
[TBL] [Abstract][Full Text] [Related]
8. Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
Solimani F; Meier K; Ghoreschi K
Eur J Immunol; 2021 May; 51(5):1071-1075. PubMed ID: 33675065
[TBL] [Abstract][Full Text] [Related]
9. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
Thepmankorn P; Bach J; Lasfar A; Zhao X; Souayah S; Chong ZZ; Souayah N
Cytokine; 2021 Feb; 138():155404. PubMed ID: 33360025
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
11. Controlling Cytokine Storm Is Vital in COVID-19.
Tang L; Yin Z; Hu Y; Mei H
Front Immunol; 2020; 11():570993. PubMed ID: 33329533
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
[TBL] [Abstract][Full Text] [Related]
13. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Soy M; Keser G; Atagündüz P; Tabak F; Atagündüz I; Kayhan S
Clin Rheumatol; 2020 Jul; 39(7):2085-2094. PubMed ID: 32474885
[TBL] [Abstract][Full Text] [Related]
14. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?
Bellgrau D; Modiano JF
Scand J Immunol; 2021 Mar; 93(3):e12979. PubMed ID: 32991014
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
[TBL] [Abstract][Full Text] [Related]
16. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
17. The potential association between PARP14 and SARS-CoV-2 infection (COVID-19).
Tauber AL; Schweiker SS; Levonis SM
Future Med Chem; 2021 Mar; 13(6):587-592. PubMed ID: 33467912
[TBL] [Abstract][Full Text] [Related]
18. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword.
Tan LY; Komarasamy TV; Rmt Balasubramaniam V
Front Immunol; 2021; 12():742941. PubMed ID: 34659238
[TBL] [Abstract][Full Text] [Related]
19. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
20. "Cytokine storm", not only in COVID-19 patients. Mini-review.
Lukan N
Immunol Lett; 2020 Dec; 228():38-44. PubMed ID: 33007369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]